GPT-6 Rosalind
OpenAI · Released Oct 2026
GPT-6 Rosalind is OpenAI's reasoning model for biology, drug discovery and translational medicine, built on the same weights as GPT-6 Astra and priced at $15 input and $75 output per 1M tokens at short context. The deciding caveat: access is limited to approved organizations through OpenAI's trusted-access program, so most readers cannot call it. It suits approved life sciences research teams; everyone else should use a general model. We have not tested it.
Is it right for you?
Good for
- Approved life sciences research on biology, drug discovery and translational medicine. OpenAI's system card describes it as a frontier reasoning model for these.
- Approved research on dual-use biological topics. OpenAI's system card says Rosalind has fewer refusals on dual-use biological queries, while still refusing biological weaponization requests.
Not good for
- Anyone outside the trusted-access program. OpenAI says access is limited to approved customers.
- Long-context-heavy use on a budget. The long-context rate is $30 input and $112.50 output per 1M tokens, double the short-context input rate.
- Requests for biological weaponization. OpenAI says the model still refuses them.
How it performs by task
Medicinal chemistry
OpenAI's own rubric: 49.6% mean score vs 28.9% for GPT-Rosalind-5.5 at the highest reasoning budget tested. Vendor figure.
Genomics and quantitative biology
OpenAI's own test: 37.7% single-attempt success vs 16.7% for GPT-Rosalind-5.5. Vendor figure, and an absolute rate below 40%.
Pricing
Input
$15 / 1M tokens
Output
$75 / 1M tokens
Context
Short context shown. Long context $30 input / $112.50 output. Cached input $1.50 short, $3.00 long. Trusted-access only.
Benchmarks
No verdict changes yet
The clock starts day one. Changes land here as our verdict evolves.
Sources
- OpenAI API pricingNov 2026
- OpenAI API changelogNov 2026
- GPT-Rosalind-6 system cardNov 2026
Verification log
- Pricing· No changes
Automated agent